Stock Analysis & Valuation Cybin Inc. Common Stock (HELP)

• Previous Close: $5.15
• Sector Valuation Confidence Level: High

Valuation method	Value, $	Upside, %
Artificial intelligence (AI)	n/a	n/a
Intrinsic value (DCF)		n/a
Graham-Dodd Method		n/a
Graham Formula		n/a

Company Information

http://www.cybin.com

100 King Street West

Toronto, ON M5X 1C9

Canada

Phone: [phone]

Industry: Biotechnology

Sector: Healthcare

CEO: Michael F. Cola

Full Time Employees: 50

Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder